Noemi Lois: recent advances on diabetic retinopathy
Noemi Lois: recent advances on diabetic retinopathy
来源期刊： 眼科学报 |
2016年9月 第31卷 第3期： |
209-210
发布时间：
收稿时间：2024/12/2 20:04:33
阅读量：8
- 作者：
-
- 关键词：
-
-
- DOI：
-
doi: 10.3978/j.issn.1000-4432.2016.09.08
- 收稿时间：
-
2016-06-30
- 修订日期：
-
- 接收日期：
-
2016-07-05
Introduction
Noemi Lois (Figure 1) currently serves as a clinical professor
in School of Medicine, Dentistry and Biomedical Sciences
in Queen’s University in UK. Dr. Lois leads a program of
preclinical and clinical research into diabetic retinopathy
and its complications (diabetic macular oedema and
proliferative diabetic retinopathy. Prof. Lois has published
over 100 articles in peer review journals, 13 book chapters
and is the editor of 3 textbooks, one on its second edition.
Figure 1 Dr. Noemi Lois.
YKXB: What do you think of this symposium?
Dr. Lois: I really enjoy this symposium. I think it is
informative. I also enjoy the lectures presented by the
experts. I learnt a lot from it.
YKXB: Could you brief us the status quo of the diabetic
retinopathy?
Dr. Lois: For many years, many researches have invested
plenty of time to figure out why the disease occurs, why
some patients are more severe than others. Despite of these
researches, we still don’t fully understand why this happens.
Therefore, more researches are required to be conducted to
help us understand better about the diabetic retinopathy. I
think we still have a lot of things to do.
YKXB： Could you share with us the recent research
advances in diabetic retinopathy?
Dr. Lois: Sure. First of all, the diabetic retinopathy
screening program is running more successful in many
countries now. With the help of it, we are able to identify
the disease earlier. Secondly, more treatments are available
for the patients. We could try to identify the kinds of
therapies that an individual might respond better. Also,
there is a progress in the understanding about the cause of
the disease.
YKXB: How to prevent diabetic retinopathy complication
in your opinion?
Dr. Lois: Prevention is one of the major things. We should
ffnd a less costly treatment without major risks for the patients,
which is also hopefully effective to those people who are in
higher risk in blindness. We should also do more studies on
prevention of the development of complication in patients.
YKXB: What is your opinion about treatment of diabetic
retinopathy?
Dr. Lois: Now, we have better treatment than we used
to have. However, even with the treatment that could be
offered, only about 50–60% of patients have improvement
in their conditions. We still need to do a lot of work to find
a better, more friendly treatment.
YKXB: Why did you choose to be an ophthalmologist?
Dr. Lois: Well, I became interested in ophthalmology quite
early on. It can be traced back to the time when I began to
study medicine. I thought it was very attractive. I always
liked surgery and the medical aspects of ophthalmology. I think the medical aspects of ophthalmology is a very
challenging field, which I am now still working on.
Ophthalmology allows me to do surgery and to conduct
researches on medical aspects of ophthalmology.
For more details about this interview, readers can refer to
the following video (Figure 2).
Figure 2 Noemi Lois: recent advances on diabetic retinopathy (1).
Available online: http://www.asvide.com/articles/1157
1、Ye A. Noemi Lois: recent advances on diabetic retinopathy. Asvide 2016;3:383. Available online: http://www.asvide.com/articles/1157
